claim: fda gives eua to saliva-based test kit
evidence_1: coronavirus (covid-19) update: fda issues emergency use authorization to yale school of public health for salivadirect, which uses a new method of saliva sample processing 1.", "coronavirus (covid-19) update: fda authorizes first diagnostic test using at-home collection of saliva specimens 1.", "the fda has authorized more than 80 covid-19 tests and adding more options for at-home sample collection is an important advancement in diagnostic testing during this public health emergency. todays eua for rutgers clinical genomics laboratorys molecular test permits testing of a saliva sample collected from the patient using a designated self- collection kit.", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "specifically, the fda issued an emergency use authorization (eua) to rutgers clinical genomics laboratory for their covid-19 laboratory developed test (ldt), which had been previously added to the high complexity molecular- based ldt umbrella eua, to permit testing of samples self-collected by patients at home using the spectrum solutions llc sdna-1000 saliva collection device.", "while fda has seen variable performance in tests using saliva, yale school of public health submitted data with its eua request from which the fda determined that yales test meets the criteria for emergency authorization when used to test saliva samples for sars-cov-2, the virus that causes covid-19 infection."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )